Uncovering the role of hypoxia inducible factor-1α in skin carcinogenesis

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1816, Issue 1, 2011, Pages 1-12

  Nys, Kris ^a   Maes, Hannelore ^a   Dudek, Aleksandra Maria ^a   Agostinis, Patrizia ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Apoptosis; Carcinogenesis; CMM; HIF 1 ; Keratinocytes; Melanocytes; Mild hypoxia; SCC; Skin cancer; UVB

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA;

APOPTOSIS; AUTOPHAGY; BASAL CELL CARCINOMA; CANCER GROWTH; CANCER RISK; CARCINOGENICITY; CELL HYPOXIA; CELLULAR STRESS RESPONSE; EPIDERMIS CELL; HUMAN; KERATINOCYTE; LIGHT EXPOSURE; MALIGNANT TRANSFORMATION; MELANOCYTE; MELANOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; SKIN CANCER; SKIN CARCINOGENESIS; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; SUNBURN; ULTRAVIOLET B RADIATION;

ANIMALS; CELL HYPOXIA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOPLASMS, RADIATION-INDUCED; SKIN; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 79952702980     PISSN: 0304419X     EISSN: 0304419X     Source Type: Journal    
DOI: 10.1016/j.bbcan.2011.02.001     Document Type: Review

References (117)

1. Lippens S., Hoste E., Vandenabeele P., Agostinis P., Declercq W. Cell death in the skin. Apoptosis 2009, 14:549.
2. Lee J.T., Herlyn M. Microenvironmental influences in melanoma progression. J. Cell. Biochem. 2007, 101:862.
3. Costin G.E., Hearing V.J. Human skin pigmentation: melanocytes modulate skin color in response to stress. FASEB J. 2007, 21:976.
4. Evans S.M., Schrlau A.E., Chalian A.A., Zhang P., Koch C.J. Oxygen levels in normal and previously irradiated human skin as assessed by EF5 binding. J. Invest. Dermatol. 2006, 126:2596.
5. Boutin A.T., Weidemann A., Fu Z., Mesropian L., Gradin K., Jamora C., Wiesener M., Eckardt K.U., Koch C.J., Ellies L.G., Haddad G., Haase V.H., Simon M.C., Poellinger L., Powell F.L., Johnson R.S. Epidermal sensing of oxygen is essential for systemic hypoxic response. Cell 2008, 133:223.
6. Bedogni B., Powell M.B. Skin hypoxia: a promoting environmental factor in melanomagenesis. Cell Cycle 2006, 5:1258.
7. Semenza G.L. Hypoxia-inducible factor 1 (HIF-1) pathway. Sci. STKE 2007, 2007:cm8.
8. Wiesener M.S., Jurgensen J.S., Rosenberger C., Scholze C.K., Horstrup J.H., Warnecke C., Mandriota S., Bechmann I., Frei U.A., Pugh C.W., Ratcliffe P.J., Bachmann S., Maxwell P.H., Eckardt K.U. Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs. FASEB J. 2003, 17:271.
9. Loboda A., Jozkowicz A., Dulak J. HIF-1 and HIF-2 transcription factors-similar but not identical. Mol. Cells 2010, 29:435.
10. Aragones J., Fraisl P., Baes M., Carmeliet P. Oxygen sensors at the crossroad of metabolism. Cell Metab. 2009, 9:11.
11. Safran M., Kaelin W.G. HIF hydroxylation and the mammalian oxygen-sensing pathway. J. Clin. Invest. 2003, 111:779.
12. Kaelin W.G., Ratcliffe P.J. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol. Cell 2008, 30:393.
13. Hamanaka R.B., Chandel N.S. Mitochondrial reactive oxygen species regulate hypoxic signaling. Curr. Opin. Cell Biol. 2009, 21:894.
14. Bedogni B., Powell M.B. Hypoxia, melanocytes and melanoma-survival and tumor development in the permissive microenvironment of the skin. Pigment Cell Melanoma Res. 2009, 22:166.
15. Scortegagna M., Martin R.J., Kladney R.D., Neumann R.G., Arbeit J.M. Hypoxia-inducible factor-1alpha suppresses squamous carcinogenic progression and epithelial-mesenchymal transition. Cancer Res. 2009, 69:2638.
16. Cho Y.S., Bae J.M., Chun Y.S., Chung J.H., Jeon Y.K., Kim I.S., Kim M.S., Park J.W. HIF-1alpha controls keratinocyte proliferation by up-regulating p21(WAF1/Cip1). Biochim. Biophys. Acta 2008, 1783:323.
17. Biswas S., Roy S., Banerjee J., Hussain S.R., Khanna S., Meenakshisundaram G., Kuppusamy P., Friedman A., Sen C.K. Hypoxia inducible microRNA 210 attenuates keratinocyte proliferation and impairs closure in a murine model of ischemic wounds. Proc. Natl. Acad. Sci. USA 2010, 107:6976.
18. Peyssonnaux C., Boutin A.T., Zinkernagel A.S., Datta V., Nizet V., Johnson R.S. Critical role of HIF-1alpha in keratinocyte defense against bacterial infection. J. Invest. Dermatol. 2008, 128:1964.
19. Werth N., Beerlage C., Rosenberger C., Yazdi A.S., Edelmann M., Amr A., Bernhardt W., von E.C., Becker K., Schafer A., Peschel A., Kempf V.A. Activation of hypoxia inducible factor 1 is a general phenomenon in infections with human pathogens. PLoS One 2010, 5:e11576.
20. Herrlich P., Karin M., Weiss C. Supreme EnLIGHTenment: damage recognition and signaling in the mammalian UV response. Mol. Cell 2008, 29:279.
21. Afaq F., Adhami V.M., Mukhtar H. Photochemoprevention of ultraviolet B signaling and photocarcinogenesis. Mutat. Res. 2005, 571:153.
22. de Gruijl F.R., van Kranen H.J., Mullenders L.H. UV-induced DNA damage, repair, mutations and oncogenic pathways in skin cancer. J. Photochem. Photobiol. B 2001, 63:19.
23. Kulms D., Schwarz T. Independent contribution of three different pathways to ultraviolet-B-induced apoptosis. Biochem. Pharmacol. 2002, 64:837.
24. Assefa Z., Van Laethem A., Garmyn M., Agostinis P. Ultraviolet radiation-induced apoptosis in keratinocytes: on the role of cytosolic factors. Biochim. Biophys. Acta 2005, 1755:90.
25. Grossman D., Kim P.J., Blanc-Brude O.P., Brash D.E., Tognin S., Marchisio P.C., Altieri D.C. Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53. J. Clin. Invest. 2001, 108:991.
26. Takahashi H., Honma M., Ishida-Yamamoto A., Namikawa K., Miwa A., Okado H., Kiyama H., Iizuka H. In vitro and in vivo transfer of bcl-2 gene into keratinocytes suppresses UVB-induced apoptosis. Photochem. Photobiol. 2001, 74:579.
27. Sitailo L.A., Tibudan S.S., Denning M.F. Activation of caspase-9 is required for UV-induced apoptosis of human keratinocytes. J. Biol. Chem. 2002, 277:19346.
28. Zimmermann K.C., Bonzon C., Green D.R. The machinery of programmed cell death. Pharmacol. Ther. 2001, 92:57.
29. Latonen L., Laiho M. Cellular UV damage responses-functions of tumor suppressor p53. Biochim. Biophys. Acta 2005, 1755:71.
30. Ziegler A., Jonason A.S., Leffell D.J., Simon J.A., Sharma H.W., Kimmelman J., Remington L., Jacks T., Brash D.E. Sunburn and p53 in the onset of skin cancer. Nature 1994, 372:773.
31. Bruins W., Zwart E., Attardi L.D., Iwakuma T., Hoogervorst E.M., Beems R.B., Miranda B., van Oostrom C.T., van den B.J., van den Aardweg G.J., Lozano G., van S.H., Jacks T., de V.A. Increased sensitivity to UV radiation in mice with a p53 point mutation at Ser389. Mol. Cell Biol. 2004, 24:8884.
32. Benjamin C.L., Ananthaswamy H.N. p53 and the pathogenesis of skin cancer. Toxicol. Appl. Pharmacol. 2007, 224:241.
33. Chaturvedi V., Sitailo L.A., Qin J.Z., Bodner B., Denning M.F., Curry J., Zhang W., Brash D., Nickoloff B.J. Knockdown of p53 levels in human keratinocytes accelerates Mcl-1 and Bcl-x(L) reduction thereby enhancing UV-light induced apoptosis. Oncogene 2005, 24:5299.
34. Schafer M., Dutsch S., auf dem K.U., Navid F., Schwarz A., Johnson D.A., Johnson J.A., Werner S. Nrf2 establishes a glutathione-mediated gradient of UVB cytoprotection in the epidermis. Genes Dev. 2010, 24:1045.
35. Schafer M., Dutsch S., auf dem K.U., Werner S. Nrf2: a central regulator of UV protection in the epidermis. Cell Cycle 2010, 9:2917.
36. Nys K., Van L.A., Michiels C., Rubio N., Piette J.G., Garmyn M., Agostinis P. A p38(MAPK)/HIF-1 pathway initiated by UVB irradiation is required to induce Noxa and apoptosis of human keratinocytes. J. Invest. Dermatol. 2010, 130:2269.
37. Rezvani H.R., Dedieu S., North S., Belloc F., Rossignol R., Letellier T., de V.H., Taieb A., Mazurier F. Hypoxia-inducible factor-1alpha, a key factor in the keratinocyte response to UVB exposure. J. Biol. Chem. 2007, 282:16413.
38. Naik E., Michalak E.M., Villunger A., Adams J.M., Strasser A. Ultraviolet radiation triggers apoptosis of fibroblasts and skin keratinocytes mainly via the BH3-only protein Noxa. J. Cell Biol. 2007, 176:415.
39. Greijer A.E., van der W.E. The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J. Clin. Pathol. 2004, 57:1009.
40. Kothari S., Cizeau J., Millan-Ward E., Israels S.J., Bailes M., Ens K., Kirshenbaum L.A., Gibson S.B. BNIP3 plays a role in hypoxic cell death in human epithelial cells that is inhibited by growth factors EGF and IGF. Oncogene 2003, 22:4734.
41. Kim J.Y., Ahn H.J., Ryu J.H., Suk K., Park J.H. BH3-only protein Noxa is a mediator of hypoxic cell death induced by hypoxia-inducible factor 1alpha. J. Exp. Med. 2004, 199:113.
42. Pouyssegur J., Mechta-Grigoriou F. Redox regulation of the hypoxia-inducible factor. Biol. Chem. 2006, 387:1337.
43. Wunderlich L., Paragh G., Wikonkal N.M., Banhegyi G., Karpati S., Mandl J. UVB induces a biphasic response of HIF-1alpha in cultured human keratinocytes. Exp. Dermatol. 2008, 17:335.
44. Van Laethem A., Nys K., Van Kelst S., Claerhout S., Ichijo H., Vandenheede J.R., Garmyn M., Agostinis P. Apoptosis signal regulating kinase-1 connects reactive oxygen species to p38 MAPK-induced mitochondrial apoptosis in UVB-irradiated human keratinocytes. Free Radic. Biol. Med. 2006, 41:1361.
45. Wang H., Kochevar I.E. Involvement of UVB-induced reactive oxygen species in TGF-beta biosynthesis and activation in keratinocytes. Free Radic. Biol. Med. 2005, 38:890.
46. Beak S.M., Lee Y.S., Kim J.A. NADPH oxidase and cyclooxygenase mediate the ultraviolet B-induced generation of reactive oxygen species and activation of nuclear factor-kappaB in HaCaT human keratinocytes. Biochimie 2004, 86:425.
47. Van Laethem A., Van Kelst S., Lippens S., Declercq W., Vandenabeele P., Janssens S., Vandenheede J.R., Garmyn M., Agostinis P. Activation of p38 MAPK is required for Bax translocation to mitochondria, cytochrome c release and apoptosis induced by UVB irradiation in human keratinocytes. FASEB J. 2004, 18:1946.
48. Deng J., Harding H.P., Raught B., Gingras A.C., Berlanga J.J., Scheuner D., Kaufman R.J., Ron D., Sonenberg N. Activation of GCN2 in UV-irradiated cells inhibits translation. Curr. Biol. 2002, 12:1279.
49. Jiang H.Y., Wek R.C. GCN2 phosphorylation of eIF2alpha activates NF-kappaB in response to UV irradiation. Biochem. J. 2005, 385:371.
50. Wu S., Hu Y., Wang J.L., Chatterjee M., Shi Y., Kaufman R.J. Ultraviolet light inhibits translation through activation of the unfolded protein response kinase PERK in the lumen of the endoplasmic reticulum. J. Biol. Chem. 2002, 277:18077.
51. Rezvani H.R., Mahfouf W., Ali N., Chemin C., Ged C., Kim A.L., de V.H., Taieb A., Bickers D.R., Mazurier F. Hypoxia-inducible factor-1alpha regulates the expression of nucleotide excision repair proteins in keratinocytes. Nucleic Acids Res. 2010, 38:797.
52. Cho Y.S., Kim C.H., Park J.W. Involvement of HIF-1alpha in UVB-induced epidermal hyperplasia. Mol. Cells 2009, 28:537.
53. Koshiji M., Kageyama Y., Pete E.A., Horikawa I., Barrett J.C., Huang L.E. HIF-1alpha induces cell cycle arrest by functionally counteracting Myc. EMBO J. 2004, 23:1949.
54. Busca R., Berra E., Gaggioli C., Khaled M., Bille K., Marchetti B., Thyss R., Fitsialos G., Larribere L., Bertolotto C., Virolle T., Barbry P., Pouyssegur J., Ponzio G., Ballotti R. Hypoxia-inducible factor 1{alpha} is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells. J. Cell Biol. 2005, 170:49.
55. Miller A.J., Mihm M.C. Melanoma. N. Engl. J. Med. 2006, 355:51.
56. Michaloglou C., Vredeveld L.C., Soengas M.S., Denoyelle C., Kuilman T., van der Horst C.M., Majoor D.M., Shay J.W., Mooi W.J., Peeper D.S. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 2005, 436:720.
57. Maddodi N., Huang W., Havighurst T., Kim K., Longley B.J., Setaluri V. Induction of autophagy and inhibition of melanoma growth in vitro and in vivo by hyperactivation of oncogenic BRAF. J. Invest. Dermatol. 2010, 130:1657.
58. Cheung M., Sharma A., Madhunapantula S.V., Robertson G.P. Akt3 and mutant V600E B-Raf cooperate to promote early melanoma development. Cancer Res. 2008, 68:3429.
59. Govindarajan B., Sligh J.E., Vincent B.J., Li M., Canter J.A., Nickoloff B.J., Rodenburg R.J., Smeitink J.A., Oberley L., Zhang Y., Slingerland J., Arnold R.S., Lambeth J.D., Cohen C., Hilenski L., Griendling K., Martinez-Diez M., Cuezva J.M., Arbiser J.L. Overexpression of Akt converts radial growth melanoma to vertical growth melanoma. J. Clin. Invest. 2007, 117:719.
60. Chudnovsky Y., Adams A.E., Robbins P.B., Lin Q., Khavari P.A. Use of human tissue to assess the oncogenic activity of melanoma-associated mutations. Nat. Genet. 2005, 37:745.
61. Bedogni B., Welford S.M., Cassarino D.S., Nickoloff B.J., Giaccia A.J., Powell M.B. The hypoxic microenvironment of the skin contributes to Akt-mediated melanocyte transformation. Cancer Cell 2005, 8:443.
62. Kumar S.M., Yu H., Edwards R., Chen L., Kazianis S., Brafford P., Acs G., Herlyn M., Xu X. Mutant V600E BRAF increases hypoxia inducible factor-1alpha expression in melanoma. Cancer Res. 2007, 67:3177.
63. Bedogni B., Warneke J.A., Nickoloff B.J., Giaccia A.J., Powell M.B. Notch1 is an effector of Akt and hypoxia in melanoma development. J. Clin. Invest. 2008, 118:3660.
64. Gustafsson M.V., Zheng X., Pereira T., Gradin K., Jin S., Lundkvist J., Ruas J.L., Poellinger L., Lendahl U., Bondesson M. Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev. Cell 2005, 9:617.
65. Massi D., Tarantini F., Franchi A., Paglierani M., Di S.C., Pellerito S., Leoncini G., Cirino G., Geppetti P., Santucci M. Evidence for differential expression of Notch receptors and their ligands in melanocytic nevi and cutaneous malignant melanoma. Mod. Pathol. 2006, 19:246.
66. Pinnix C.C., Lee J.T., Liu Z.J., McDaid R., Balint K., Beverly L.J., Brafford P.A., Xiao M., Himes B., Zabierowski S.E., Yashiro-Ohtani Y., Nathanson K.L., Bengston A., Pollock P.M., Weeraratna A.T., Nickoloff B.J., Pear W.S., Capobianco A.J., Herlyn M. Active Notch1 confers a transformed phenotype to primary human melanocytes. Cancer Res. 2009, 69:5312.
67. Denko N.C. Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat. Rev. Cancer 2008, 8:705.
68. Semenza G.L. HIF-1: upstream and downstream of cancer metabolism. Curr. Opin. Genet. Dev. 2010, 20:51.
69. Robey R.B., Hay N. Is Akt the "Warburg kinase"?-Akt-energy metabolism interactions and oncogenesis. Semin. Cancer Biol. 2009, 19:25.
70. Mizushima N., Levine B., Cuervo A.M., Klionsky D.J. Autophagy fights disease through cellular self-digestion. Nature 2008, 451:1069.
71. Levine B., Klionsky D.J. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev. Cell 2004, 6:463.
72. He C., Klionsky D.J. Regulation mechanisms and signaling pathways of autophagy. Annu. Rev. Genet. 2009, 43:67.
73. Cash T.P., Pan Y., Simon M.C. Reactive oxygen species and cellular oxygen sensing. Free Radic. Biol. Med. 2007, 43:1219.
74. Zhang H., Bosch-Marce M., Shimoda L.A., Tan Y.S., Baek J.H., Wesley J.B., Gonzalez F.J., Semenza G.L. Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J. Biol. Chem. 2008, 283:10892.
75. Novak I., Kirkin V., McEwan D.G., Zhang J., Wild P., Rozenknop A., Rogov V., Lohr F., Popovic D., Occhipinti A., Reichert A.S., Terzic J., Dotsch V., Ney P.A., Dikic I. Nix is a selective autophagy receptor for mitochondrial clearance. EMBO Rep. 2010, 11:45.
76. Ding W.X., Ni H.M., Li M., Liao Y., Chen X., Stolz D.B., Dorn G.W., Yin X.M. Nix is critical to two distinct phases of mitophagy, reactive oxygen species-mediated autophagy induction and Parkin-ubiquitin-p62-mediated mitochondrial priming. J. Biol. Chem. 2010, 285:27879.
77. White E., DiPaola R.S. The double-edged sword of autophagy modulation in cancer. Clin. Cancer Res. 2009, 15:5308.
78. Morselli E., Galluzzi L., Kepp O., Vicencio J.M., Criollo A., Maiuri M.C., Kroemer G. Anti- and pro-tumor functions of autophagy. Biochim. Biophys. Acta 2009, 1793:1524.
79. Mazure N.M., Pouyssegur J. Hypoxia-induced autophagy: cell death or cell survival?. Curr. Opin. Cell Biol. 2010, 22:177.
80. Bellot G., Garcia-Medina R., Gounon P., Chiche J., Roux D., Pouyssegur J., Mazure N.M. Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Mol. Cell. Biol. 2009, 29:2570.
81. White E., Karp C., Strohecker A.M., Guo Y., Mathew R. Role of autophagy in suppression of inflammation and cancer. Curr. Opin. Cell Biol. 2010, 22:212.
82. Mathew R., Kongara S., Beaudoin B., Karp C.M., Bray K., Degenhardt K., Chen G., Jin S., White E. Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev. 2007, 21:1367.
83. Mathew R., Karp C.M., Beaudoin B., Vuong N., Chen G., Chen H.Y., Bray K., Reddy A., Bhanot G., Gelinas C., DiPaola R.S., Karantza-Wadsworth V., White E. Autophagy suppresses tumorigenesis through elimination of p62. Cell 2009, 137:1062.
84. Karbowniczek M., Spittle C.S., Morrison T., Wu H., Henske E.P. mTOR is activated in the majority of malignant melanomas. J. Invest. Dermatol. 2008, 128:980.
85. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 2003, 3:721.
86. Yang M.H., Wu M.Z., Chiou S.H., Chen P.M., Chang S.Y., Liu C.J., Teng S.C., Wu K.J. Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat. Cell Biol. 2008, 10:295.
87. Erler J.T., Giaccia A.J. Lysyl oxidase mediates hypoxic control of metastasis. Cancer Res. 2006, 66:10238.
88. Levental K.R., Yu H., Kass L., Lakins J.N., Egeblad M., Erler J.T., Fong S.F., Csiszar K., Giaccia A., Weninger W., Yamauchi M., Gasser D.L., Weaver V.M. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 2009, 139:891.
89. Hickey M.M., Simon M.C. Regulation of angiogenesis by hypoxia and hypoxia-inducible factors. Curr. Top. Dev. Biol. 2006, 76:217.
90. Du R., Lu K.V., Petritsch C., Liu P., Ganss R., Passegue E., Song H., Vandenberg S., Johnson R.S., Werb Z., Bergers G. HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell 2008, 13:206.
91. Erler J.T., Cawthorne C.J., Williams K.J., Koritzinsky M., Wouters B.G., Wilson C., Miller C., Demonacos C., Stratford I.J., Dive C. Hypoxia-mediated down-regulation of Bid and Bax in tumors occurs via hypoxia-inducible factor 1-dependent and -independent mechanisms and contributes to drug resistance. Mol. Cell. Biol. 2004, 24:2875.
92. Pouyssegur J., Dayan F., Mazure N.M. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 2006, 441:437.
93. Zhong H., De Marzo A.M., Laughner E., Lim M., Hilton D.A., Zagzag D., Buechler P., Isaacs W.B., Semenza G.L., Simons J.W. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res. 1999, 59:5830.
94. Ruan K., Song G., Ouyang G. Role of hypoxia in the hallmarks of human cancer. J. Cell. Biochem. 2009, 107:1053.
95. Tawbi H.A., Kirkwood J.M. Management of metastatic melanoma. Semin. Oncol. 2007, 34:532.
96. Rass K., Tilgen W. Treatment of melanoma and nonmelanoma skin cancer. Adv. Exp. Med. Biol. 2008, 624:296.
97. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57.
98. Monsel G., Ortonne N., Bagot M., Bensussan A., Dumaz N. c-Kit mutants require hypoxia-inducible factor 1alpha to transform melanocytes. Oncogene 2010, 29:227.
99. Takahashi Y., Nishikawa M., Takakura Y. Suppression of tumor growth by intratumoral injection of short hairpin RNA-expressing plasmid DNA targeting beta-catenin or hypoxia-inducible factor 1alpha. J. Control. Release 2006, 116:90.
100. Giatromanolaki A., Sivridis E., Kouskoukis C., Gatter K.C., Harris A.L., Koukourakis M.I. Hypoxia-inducible factors 1alpha and 2alpha are related to vascular endothelial growth factor expression and a poorer prognosis in nodular malignant melanomas of the skin. Melanoma Res. 2003, 13:493.
101. Trisciuoglio D., Gabellini C., Desideri M., Ziparo E., Zupi G., Del B.D. Bcl-2 regulates HIF-1alpha protein stabilization in hypoxic melanoma cells via the molecular chaperone HSP90. PLoS ONE 2010, 5:e11772.
102. Patel M.P., Masood A., Patel P.S., Chanan-Khan A.A. Targeting the Bcl-2. Curr. Opin. Oncol. 2009, 21:516.
103. Neckers L., Ivy S.P. Heat shock protein 90. Curr. Opin. Oncol. 2003, 15:419.
104. Nakayama K., Frew I.J., Hagensen M., Skals M., Habelhah H., Bhoumik A., Kadoya T., Erdjument-Bromage H., Tempst P., Frappell P.B., Bowtell D.D., Ronai Z. Siah2 regulates stability of prolyl-hydroxylases, controls HIF1alpha abundance, and modulates physiological responses to hypoxia. Cell 2004, 117:941.
105. Nakayama K., Qi J., Ronai Z. The ubiquitin ligase Siah2 and the hypoxia response. Mol. Cancer Res. 2009, 7:443.
106. Qi J., Nakayama K., Gaitonde S., Goydos J.S., Krajewski S., Eroshkin A., Bar-Sagi D., Bowtell D., Ronai Z. The ubiquitin ligase Siah2 regulates tumorigenesis and metastasis by HIF-dependent and -independent pathways. Proc. Natl. Acad. Sci. USA 2008, 105:16713.
107. Mills C.N., Joshi S.S., Niles R.M. Expression and function of hypoxia inducible factor-1 alpha in human melanoma under non-hypoxic conditions. Mol. Cancer 2009, 8:104.
108. Kuphal S., Winklmeier A., Warnecke C., Bosserhoff A.K. Constitutive HIF-1 activity in malignant melanoma. Eur. J. Cancer 2010, 46:1159.
109. Liou G.Y., Storz P. Reactive oxygen species in cancer. Free Radic. Res. 2010, 44:479.
110. Elson D.A., Ryan H.E., Snow J.W., Johnson R., Arbeit J.M. Coordinate up-regulation of hypoxia inducible factor (HIF)-1alpha and HIF-1 target genes during multi-stage epidermal carcinogenesis and wound healing. Cancer Res. 2000, 60:6189.
111. Lining X., Uchi H., Hayashida S., Tsuji G., Kido M., Nakahara T., Takeuchi S., Takahara M., Moroi Y., Furue M. Expression of hypoxia-inducible factor-1alpha and hypoxia-inducible factor-2alpha with progression of keratinocytic neoplasms. J. Dermatol. Sci. 2009, 56:135.
112. Ming M., He Y.Y. PTEN: new insights into its regulation and function in skin cancer. J. Invest. Dermatol. 2009, 129:2109.
113. Okuyama R., Tagami H., Aiba S. Notch signaling: its role in epidermal homeostasis and in the pathogenesis of skin diseases. J. Dermatol. Sci. 2008, 49:187.
114. Panelos J., Massi D. Emerging role of Notch signaling in epidermal differentiation and skin cancer. Cancer Biol. Ther. 2009, 8:1986.
115. Dotto G.P. Notch tumor suppressor function. Oncogene 2008, 27:5115.
116. Nicolas M., Wolfer A., Raj K., Kummer J.A., Mill P., van N.M., Hui C.C., Clevers H., Dotto G.P., Radtke F. Notch1 functions as a tumor suppressor in mouse skin. Nat. Genet. 2003, 33:416.
117. Weinberg W.C., Denning M.F. P21Waf1 control of epithelial cell cycle and cell fate. Crit. Rev. Oral Biol. Med. 2002, 13:453.